Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo.

• Main Authors: Richard Odame Phillips (Author), Delphin Mavinga Phanzu (Author), Marcus Beissner (Author), Kossi Badziklou (Author), Elysée Kalundieko Luzolo (Author), Fred Stephen Sarfo (Author), Wemboo Afiwa Halatoko (Author), Yaw Amoako (Author), Michael Frimpong (Author), Abass Mohammed Kabiru (Author), Ebekalisai Piten (Author), Issaka Maman (Author), Bawimodom Bidjada (Author), Adjaho Koba (Author), Koffi Somenou Awoussi (Author), Basile Kobara (Author), Jörg Nitschke (Author), Franz Xaver Wiedemann (Author), Abiba Banla Kere (Author), Ohene Adjei (Author), Thomas Löscher (Author), Bernhard Fleischer (Author), Gisela Bretzel (Author), Karl-Heinz Herbinger (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2015-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The only available vaccine that could be potentially beneficial against mycobacterial diseases contains live attenuated bovine tuberculosis bacillus (Mycobacterium bovis) also called Bacillus Calmette-Guérin (BCG). Even though the BCG vaccine is still widely used, results on its effectiveness in pr...